Excipients in the Paediatric Population

The development of paediatric medicines presents unique challenges, not least among them the careful selection and use of excipients. While often considered inert, excipients play crucial roles in drug formulation, influencing everything from solubility and stability to palatability and bioavailability. In the paediatric population, the physiological immaturity of infants and children necessitates an even more stringent evaluation of excipient safety and suitability, as certain excipients well-tolerated in adults can be harmful or even toxic in younger patients. Here, we will delve into the critical considerations surrounding excipients in paediatric formulations, highlighting excipients that are generally considered safe and effective for this vulnerable population, and outlining strategic approaches for their appropriate use.

Unique Considerations in Paediatrics

Children are not merely "small adults." Differences in metabolic pathways, organ function, and enzymatic activity mean that excipients safe for adults may be harmful or inadequately tolerated in younger patients. For example:

• Immature Hepatic Metabolism: Certain excipients like propylene glycol or ethanol may accumulate due to underdeveloped liver enzymes (e.g., alcohol dehydrogenase).
• Renal Function: Poor clearance of excipients such as benzyl alcohol or polyethylene glycol can lead to toxicity.
• Blood-Brain Barrier Permeability: In neonates, the blood-brain barrier is more permeable, increasing the risk of neurotoxicity from certain compounds.

Excipients to Approach with Caution or Avoid in Paediatric Formulations

Several excipients commonly used in adult formulations have known or suspected risks in children and should be used with extreme caution or avoided altogether, especially in neonates and young infants:

• Ethanol: It can cause central nervous system depression, hypoglycemia, and metabolic acidosis. Its use should be minimized or avoided, especially in neonates.
• Propylene Glycol (PG): High doses can lead to hyperosmolality, lactic acidosis, seizures, and renal dysfunction, particularly in neonates and infants with immature renal function.
• Benzyl Alcohol: Associated with "gasping syndrome" in neonates, characterized by metabolic acidosis, respiratory distress, and central nervous system dysfunction.
• Parabens (Methyl, Ethyl, Propyl, Butylparaben): While generally considered safe in adults, concerns exist regarding potential endocrine disruption, especially in vulnerable populations. Their use should be carefully considered, and alternative preservatives sought where possible.
• Saccharin Sodium and Aspartame: While widely used, concerns about potential long-term effects on metabolism and gut microbiota in children have been raised, though evidence is not conclusive. Their use should be balanced with the need for palatability.
• Sorbitol: High doses can cause gastrointestinal distress, including osmotic diarrhea. Care should be taken with its concentration, especially in oral solutions.
• Colorants (Artificial Dyes): Some artificial food colorings have been linked to hyperactivity in sensitive children. While not universally banned, formulators often opt for natural alternatives or minimize their use.

Explore Our Natural Colorants

• Natural Colors

Examples of Safer Excipients for Paediatric Use

Sweeteners

Flavoring Agents

Viscosity-Modifying Agents/Suspending Agents

Solubilizers and Wetting Agents

Preservatives

Bulking Agents/Diluents (for solid oral dosage forms)

Sweeteners

They are widely used in oral paediatric formulations to improve palatability. Generally permissible and preferred excipients include:

• Sucrose: Widely accepted, but dental caries remain a concern with frequent use.
• Stevia (Steviol Glycosides): A natural, non-caloric sweetener gaining popularity, with a good safety profile.
• Thaumatin: A naturally occurring protein sweetener with an intense sweet taste and good safety profile.
• Maltitol and Xylitol: Sugar alcohols that are less cariogenic than sucrose, but can cause gastrointestinal upset in high doses.

Flavoring Agents

Masking unpleasant tastes is crucial. Natural fruit flavors (e.g., berry, orange, grape) are often preferred. Artificial flavors should be used cautiously and only if safety data are robust.

Viscosity-modifying Agents/Suspending Agents

These improve consistency and prevent settling of insoluble drugs. Generally permissible and preferred excipients include:

• Cellulose Derivatives (e.g., Microcrystalline Cellulose, Carboxymethylcellulose Sodium, Hydroxypropyl Methylcellulose (HPMC)): Widely used, generally well-tolerated, and provide good stability.
• Xanthan Gum: A natural polysaccharide, effective at low concentrations, and generally safe.
• Carrageenan: A natural polysaccharide, but some specific types (degraded carrageenan) have been associated with inflammation, so selection of food-grade carrageenan is important.
• Acacia (Gum Arabic): Natural gum, well-tolerated.

Solubilizers and Wetting Agents

They are used to improve drug solubility and dispersibility. Generally permissible and preferred excipients include:

• Polysorbate 20 and Polysorbate 80: Non-ionic surfactants, generally considered safe at appropriate concentrations, but concerns exist about potential hypersensitivity reactions in very young infants.
• Macrogols (Polyethylene Glycols - PEGs): Lower molecular weight PEGs (e.g., PEG 300, PEG 400) are generally considered safer than higher molecular weight PEGs in oral formulations, but their use in neonates should be carefully assessed due to potential renal accumulation.
• Glycerol: A simple polyol, commonly used as a solvent and humectant, generally safe.

Preservatives

They are crucial for multi-dose liquid formulations. Generally permissible and preferred excipients include:

• Sodium Benzoate and Benzoic Acid: Widely used and generally safe at recommended concentrations.
• Sorbic Acid and Potassium Sorbate: Effective antifungal agents, generally well-tolerated.

Bulking Agents/Diluents (for solid oral dosage forms)

Generally permissible and preferred excipients include:

• Lactose (Anhydrous, Monohydrate): Widely used, but consider lactose intolerance in some children.
• Mannitol: A sugar alcohol, often used in orally disintegrating tablets due to its cooling sensation and low hygroscopicity.
• Dextrose: Simple sugar, well-tolerated.
• Starch (Corn, Potato, Rice): Common and safe diluents.

Strategies for Excipient Selection in Paediatric Formulations

A systematic and risk-based approach is essential when selecting excipients for paediatric formulations.

• Age-appropriate Excipient Selection: Excipient choice must be tailored to the specific age group (e.g., neonates, infants, toddlers, pre-school, school-age, adolescents). The younger the child, the more stringent the safety requirements.
• Minimize Excipient Burden: Utilize the fewest excipients necessary to achieve the desired pharmaceutical properties. Simpler formulations often translate to reduced risk.
• Use "GRAS" (Generally Recognized As Safe) Excipients: Prioritize excipients with a long history of safe use in food or pharmaceuticals, especially those with established safety profiles in children.
• Leverage Existing Paediatric Formulations: Review approved paediatric formulations for insights into excipient choices and concentrations that have demonstrated safety and efficacy.
• Consider Alternative Routes of Administration: If oral formulation presents significant excipient challenges, explore alternative routes like transdermal or rectal, which may require different excipient profiles.
• Palatability and Acceptability Studies: Conduct taste and acceptability studies with target paediatric populations to ensure compliance and adherence. This often involves sensory panels and preference testing.
• Risk-benefit Assessment: For every excipient, a thorough risk-benefit assessment should be conducted, weighing the potential risks against the therapeutic benefits of the medication. This is particularly important for life-saving drugs where the benefits may outweigh minor excipient-related risks.
• Regulatory Guidance Adherence: Strictly adhere to the latest regulatory guidelines and recommendations from authorities such as the EMA, FDA, and national pharmacopoeias regarding excipient use in paediatric medicines.

Our company is dedicated to providing a comprehensive selection of safe and effective excipients specifically designed for the paediatric population. We understand the unique needs of children when it comes to medication and formulation, and our products are formulated to ensure optimal safety and efficacy. With a focus on quality and compliance, we aim to support pharmaceutical companies in creating the best therapeutic options for young patients.

Please kindly note that our services are for research use only.